January 2023 - Page 16 of 22

TuesdayJan 10, 2023 12:00 pm

Aditxt, Inc. (NASDAQ: ADTX) Bolsters Goal to Conduct First-In-Human Clinical Trial Evaluating ADI(TM) Tech with Formation of Adimune, Inc. Subsidiary; Appoints Industry Veteran as Subsidiary Chairman and CEO

Aditxt recently announced the formation of a U.S.-based wholly owned subsidiary, Adimune, Inc., and appointed Joachim-Friedrich Kapp, M.D., Ph.D., a 30-year veteran of the pharmaceutical industry, as its Chairman and CEO Dr. Kapp will be tasked with leading and developing the Apoptotic DNA Immunotherapy(TM) (“ADI(TM)”) technology toward clinical trials Aditxt also plans to submit a Clinical Trial Application (“CTA”) for immunotherapeutic technology drug candidate ADI(TM)-100, seeking approval for Adimune(TM) to conduct the first-in-human study in psoriasis patients, beginning in the second half of 2023 ADI(TM) is a nucleic acid-based technology platform that utilizes a novel antigen-specific approach to induce immune…

TuesdayJan 10, 2023 11:46 am

QualityStocksNewsBreaks – QSAM Biosciences Inc. (QSAM) Releases Shareholder Letter Outlining 2022 Updates, 2023 Milestone Goals

QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases, has provided key updates and milestone goals in a shareholder letter; the letter is from QSAM Biosciences executive chair and cofounder C. Richard Piazza and CEO and cofounder Douglas Baum. The letter noted that QSAM is developing its lead therapeutic radiopharmaceutical drug candidate, CycloSam, to treat cancer that has either originated in the bone or has metastasized to the bone from the breast, prostate, lung or other organs. During 2022, CycloSam received rare pediatric disease designation for the…

TuesdayJan 10, 2023 11:34 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Key Milestones, 2023 Business Outlook

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today outlined key accomplishments from 2022 and provided a business update and catalysts for 2023. “Over the course of 2022, we strengthened our position as a leader in rare cannabinoid R&D, creating a unique offering as the only company that has the breadth and depth in cannabinoid drug research, development and significant manufacturing know-how,” said Eric A. Adams, InMed president and CEO. “Despite the many economic pressures affecting businesses on a global scale, including challenging capital markets, particularly in biotech, InMed…

TuesdayJan 10, 2023 11:15 am

Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Is ‘One to Watch’

Canada Nickel in December 2022 announced positive drilling results from exploration at its Reid and Sothman properties The company in November 2022 announced recovery of valuable by-products from a processing pilot test, including cobalt, palladium, platinum and chromium Canada Nickel announced in November 2022 improvements to its accelerated CO2 capture process Canada Nickel announced in October 2022 it closed a secured loan with Auramet International of $10 million Canada Nickel has engaged Deutsche Bank and Scotiabank as financial advisors for the Crawford Nickel Sulphide Project Projections indicate that, by 2035, world demand for nickel will double from current levels to…

TuesdayJan 10, 2023 11:13 am

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Signs $31M Definitive Agreement with Roynat Capital, Export Development Canada

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has entered a definitive agreement with existing lenders Roynat Capital (a subsidiary of the Bank of Nova Scotia) and Export Development Canada (EDC). According to the announcement, the agreement outlines the terms for a $31 million syndicated senior term loan, with Roynat and EDC each providing 50% of the proceeds. The company noted that funds will be used to support the upgrade and construction of EverGen’s RNG facilities, to provide $15 million for refinancing of existing debt and construction at Fraser Valley Biogas (“FVB”) and to provide $16…

TuesdayJan 10, 2023 10:52 am

QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Begins Trading on Next-Gen Marketplace

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, announced that today at 10 a.m. EST, the company will start trading on Upstream under the ticker symbol JUPW. A revolutionary trading app for digital securities and NFTs, Upstream is powered by Horizon Fintex and MERJ Exchange Limited. The company noted that a digital collectible NFT commemorating the dual listing would be available for Upstream participants to claim using the code: JUPW. Through Upstream, investors around the world can invest in JUPW by downloading the Upstream app from their preferred app store and creating an account. Transactions…

TuesdayJan 10, 2023 10:45 am

MetAlert, Inc. (MLRT) Developing Innovative Location-Sensitive Health Monitoring and Supervision Products as It Targets Market Leadership in Telehealth Space

MetAlert is a pioneer in location-sensitive health monitoring devices and wearable technology products targeting the Alzheimer’s, Dementia, and Autism (“ADA”) market The company is looking to provide cutting-edge telehealth technologies and is continuously working to roll out improved and more innovative products for its users Its SmartSole(R) product facilitates discreet tracking and remote monitoring of ADA patients The company has also launched SmartSole plus(R), which adds Bluetooth and Wi-Fi capabilities for better tracking MetAlert also distributes RoomMate, a wall-mounted 3D infrared supervision product that enables caregivers to look after patients without intruding on their personal space The policy changes spearheaded…

TuesdayJan 10, 2023 9:45 am

SideChannel Inc. (SDCH) Helps Safeguard Vital Company Data Through vCISO Contracts That Offer Affordable Alternative to In-house Staffing, Critical for Cannabis and other SMB Operations

Cannabis companies are regarded as being particularly vulnerable to cyberattacks, including potential ransomware incidents, because of their high cash-flow operations and their small business status, heightened by remote work due to Covid Cybersecurity services and technology provider SideChannel serves the needs of emerging businesses that may be hard-pressed to hire a full-time cybersecurity expert and need an affordable alternative SideChannel provides virtual chief information security officer (“vCISO”) services on a contract basis, drawing on a collective 450 years of experience When the COVID-19 pandemic caused a wide array of industries to shut down their operations and then reopen with heightened…

TuesdayJan 10, 2023 9:00 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Capitalizing on the Abundance of Low Carbon Energy Sources

Methane, such as that in livestock waste, is up to 50% more potent than carbon dioxide in holding heat in the atmosphere EverGen is an Infrastructure platform that specializes in renewable natural gas (“RNG”) projects converting diverse types of waste into usable, green alternatives to fossil fuels EverGen’s RNG capacity will exceed 2 million gigajoules annually once its projects and expansions are complete in B.C., Alberta, and Ontario We are surrounded by untapped, atmosphere-friendly energy. The sun and wind are two popular sources today, but the problem is that it isn’t always sunny or windy. For EverGen Infrastructure (TSX.V: EVGN)…

MondayJan 09, 2023 2:12 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Kicks Off New Year with Multiple New Contracts, Announces Planned Path to Profitability

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, announced that it has secured four new contracts in a successful start of 2023. Under the contracts, Knightscope will deploy three K5 Autonomous Security Robots (“ASRs”) and five K1 Blue Light Towers. The deployment locations include an existing Knightscope channel partner’s regional corporate office in Jacksonville, Florida, an Illinois-based casino, as well as the parking lot of an apartment complex for a well-known learning institution. A teaching hospital has also purchased five K1 Blue Light Towers to improve communications and safety on its New…

Site Search

Company Search

Month: January 2023